Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AVL9 |
| Upstream (Parents) |
|---|
| (<<) PRSS8 → AVL9 |
| (<<) CENPA → AVL9 |
| (<<) MCM7 → AVL9 |
| (<<) PAK1 → AVL9 |
| (<<) CDYL → AVL9 |
| Downstream (Children) |
|---|
| AVL9 → PIAS4 (>>) |
| AVL9 → NPEPL1///STX16 (>>) |
| AVL9 → FCGR1A (>>) |
| AVL9 → P2RY2 (>>) |
| AVL9 → TPO (>>) |
| AVL9 → POLM (>>) |
| AVL9 → MMP27 (>>) |
| AVL9 → MED27 (>>) |
| AVL9 → HSF1 (>>) |
| AVL9 → RPL29P17///MBOAT1 (>>) |
| AVL9 → C17orf86 (>>) |
| AVL9 → MKS1 (>>) |
| AVL9 → VAC14 (>>) |
| AVL9 → PRSS22 (>>) |
| AVL9 → BRWD1 (>>) |
